Applying Precision Medicine to Define Predictors of Response to Ozanimod and Discovering Biomarkers in the Management of Ulcerative Colitis Using 7,000 Protein SOMAscan
Latest Information Update: 11 Jun 2025
At a glance
- Drugs Ozanimod (Primary)
- Indications Ulcerative colitis
- Focus Biomarker; Therapeutic Use
Most Recent Events
- 04 Jun 2025 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 14 Apr 2023 Planned initiation date changed from 1 Apr 2023 to 1 May 2023.
- 14 Apr 2023 New trial record